Trial · NCT03710356
Registered outcomes34
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 34
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Hematological response or Pulmonary response at M12 | 12 months | Response at 12 months is defined according to the initial pathology. Responses is defined as a composite outcome. At least one of the following item should be validated to observe response. * For patients with bone marrow failure, the hematological response at 12 months depending on initial cytopenia(s) is defined by * 1.5 g/dL increase in hemoglobin without transfusion for 2 months * And/or increase of 20.10\^9/L in platelet count without transfusion for 2 months * And/or increase of 0.5.10\^9/L in neutrophils count. * For patients with pulmonary fibrosis, a decrease of less than 5% in forced vital capacity at 12 months |
| Secondary | Hepatic tolerance M1 | 1 month | aspartate aminotransferase blood level |
| Secondary | Hepatic tolerance M2 | 2 months | aspartate aminotransferase blood level |
| Secondary | Hepatic tolerance M3 | 3 months | aspartate aminotransferase blood level |
| Secondary | Hepatic tolerance M6 | 6 months | aspartate aminotransferase blood level |
| Secondary | Hepatic tolerance M9 | 9 months | aspartate aminotransferase blood level |
| Secondary | Hepatic tolerance M12 | 12 months | aspartate aminotransferase blood level |
| Secondary | LDL cholesterol M3 | 3 months | Low-density lipoprotein (LDL) cholesterol blood level in mmol/l |
| Secondary | LDL cholesterol M6 | 6 months | Low-density lipoprotein (LDL) cholesterol blood level in mmol/l |
| Secondary | LDL cholesterol M9 | 9 months | Low-density lipoprotein (LDL) cholesterol blood level in mmol/l |
| Secondary | LDL cholesterol M12 | 12 months | Low-density lipoprotein (LDL) cholesterol blood level in mmol/l |
| Secondary | HDL cholesterol M3 | 3 months | High-density lipoprotein (LDL) cholesterol blood level in mmol/l |
| Secondary | HDL cholesterol M6 | 6 months | High-density lipoprotein (LDL) cholesterol blood level in mmol/l |
| Secondary | HDL cholesterol M9 | 9 months | High-density lipoprotein (LDL) cholesterol blood level in mmol/l |
| Secondary | HDL cholesterol M12 | 12 months | High-density lipoprotein (LDL) cholesterol blood level in mmol/l |
| Secondary | TG M3 | 3 months | triglycerides blood level in mmol/l |
| Secondary | TG M6 | 6 months | triglycerides blood level in mmol/l |
| Secondary | TG M9 | 9 months | triglycerides blood level in mmol/l |
| Secondary | TG M12 | 12 months | triglycerides blood level in mmol/l |
| Secondary | PSA M3 | 3 months | Prostate-specific antigen (PSA) blood level for men |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03710356/registered